Mold and Mycotoxin Illness with Jodie Dashore

by

We interviewed Jodie Dashore PhD, OTD, MSc about mold and mycotoxin illness. Mycotoxins are toxic chemicals produced by fungi such as mold that can cause disease and even death.


Many practitioners report that addressing mold and mycotoxin illness can significantly help if a client has hit a plateau in symptom relief. Patients who address the possibility of mold and mycotoxin illness often report that treating it was the single biggest factor in reversal of symptoms.

Mold and mycotoxin illness can play a significant role in the etiology of:

Common symptoms are:

  • Fatigue
  • Respiratory problems
  • Problems with memory, concentration and focus
  • Joint and muscle pain
  • Headaches
  • Nose bleeds
  • Unexplained digestive problems
  • Unusual pains
  • Frequent urination
  • Night sweats
  • Tingling
  • Numbness

Please note that you will be asked to enter your email address at the 30-minute mark to finish viewing the video.

About Jodie Dashore PhD OTD MSc

Dr. Jodie A. Dashore is an internationally recognized pioneering clinician in autism, biotoxin illness, chronic inflammatory response syndrome, and Lyme disease.

As a member of ILADS (International Lyme and Associated Diseases Society) and a Lyme-literate naturopathic clinician since 2010, Dr. Dashore has an excellent track record using all natural protocols for helping patients with chronic and treatment-resistant Lyme disease.

Dr. Dashore received her PhD in integrative medicine with her thesis focus on medical herbalism for autism. She also holds a doctorate in occupational therapy specializing in neurology with her thesis focus on traumatic brain injury and stroke. She additionally holds a post-doctoral specialization in advanced neuro-sensory integration.

You can find out more about her at her website: www.bionexushealth.com

Disclaimer

This webinar is not a substitute for medical advice, treatment, diagnosis, or consultation with a medical professional. It is intended for general informational purposes only and should not be relied on to make determinations related to treatment of a medical condition. Epidemic Answers has not verified and does not guaranty the accuracy of the information provided in this webinar.

Sources & References

Baker, S., et al. Case Study: Rapid Complete Recovery From An Autism Spectrum Disorder After Treatment of Aspergillus With The Antifungal Drugs Itraconazole And Sporanox. Integr Med (Encenitas). 2020 Aug;19(4):20-27.

Bennett, J.W., et al. Mycotoxins. Clinical Microbiology Reviews. Jul 2003: 497-516.

Berndtson, K., et al. Medically sound investigation and remediation of water-damaged buildings in cases of CIRS-WDB. Center for Research on Biotoxin Associated Illness. 2016 Jan 19.

Berry, Y. A Physician’s Guide to Understanding and Treating Biotoxin Illness. 2014.

de Allori, M.C.G., et al. Antimicrobial resistance and production of biofilms in clinical isolates of coagulase-negative Staphylococcus strains. Biol Pharm Bull. 2006 Aug;29(8):1592-6.

De Santis, B., et al. Role of mycotoxins in the pathobiology of autism: A first evidence. Nutr Neurosci. 2019 Feb;22(2):132-144.

De Santis, B., et al. Study on the Association among Mycotoxins and other Variables in Children with Autism. Toxins (Basel). 2017 Jun 29;9(7):203.

Hope, J. A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins. ScientificWorldJournal. 2013 Apr 18;2013:767482.

Hudnell, H.K. Chronic biotoxin-associated illness: multiple-system symptoms, a vision deficit, and effective treatment. Neurotoxicol Teratol. Sep-Oct 2005;27(5):733-43.

Institute of Medicine (US) Committee on Damp Indoor Spaces and Health. Damp Indoor Spaces and Health. Washington (DC): National Academies Press (US); 2004.

Kali, A. Antibiotics and bioactive natural products in treatment of methicillin resistant Staphylococcus aureus: A brief review. Pharmacogn Rev. Jan-Jun 2015;9(17):29-34.

Kontoyiannis, D.P., et al. Treatment principles for the management of mold infections. Cold Spring Harb Perspect Med. 2014 Nov 6;5(4):a019737.

Oliva, A., et al. High Potency of Melaleuca alternifolia Essential Oil against Multi-Drug Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus aureus. Molecules. 2018 Oct 9;23(10):2584.

Ratnaseelen, A.M., et al. Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes. Clin Ther. 2018 Jun;40(6):903-917.

Salari, M.H., et al. Antibacterial effects of Eucalyptus globulus leaf extract on pathogenic bacteria isolated from specimens of patients with respiratory tract disorders. Clin Microbiol Infect. 2006 Feb;12(2):194-6.

Shoemaker, R.C., et al. Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms. Neurotoxicol Teratol. Sep-Oct 2006;28(5):573-88.

Shoemaker, R.C., et al. Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings: a volumetric MRI study using NeuroQuant®. Neurotoxicol Teratol. Sep-Oct 2014;45:18-26.

Shoemaker, R.C., et al. A time-series study of sick building syndrome: chronic, biotoxin-associated illness from exposure to water-damaged buildings. Neurotoxicol Teratol. Jan-Feb 2005;27(1):29-46.

Back to webinars